Vial strength 5 mg 10 mg 20 mg Tesamorelin Dosage Chart This tesamorelin dosage chart translates the 2 mg once-daily subcutaneous schedule evaluated in phase 3 research into a 10 mg vial prepared to 3.33 mg/mL. It shows the matching U-100 syringe units, vial yield, supplies, and evidence limits. The current EGRIFTA SV label uses … Continue reading Tesamorelin (10 mg Vial) Dosage Protocol